Correspondingly, knockdown of EphB4 in several cancer cell lines consistently resulted in a 70–80% reduction in cancer cell viability, an 8–16 fold increase in apoptosis and up to an 80% reduction in cell migration and invasion [6, 11]. Here, EPHB4 is linked to cancer.